# FDA Inspection 1160499 - Octapharma Plasma Inc - December 30, 2021

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/24288e52-3fcc-40f3-86c0-e40f14d2ce01
Source feed: FDA_Inspections

> FDA Inspection 1160499 for Octapharma Plasma Inc on December 30, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1160499
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2021-12-30
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1160499 - 2021-12-30](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/a95c12ee-abd8-49a2-be48-a8fb2020daed)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/46f3e13b-671f-4e76-ab66-a35ee8030466

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d